This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

The International AIDS Vaccine Initiative (IAVI) in a Changing Landscape of Vaccine Development: A Public/Private Partnership as Knowledge Broker and Integrator

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Joanna Chataway
Stefano Brusoni
Eugenia Cacciatori
Rebecca Hanlin
Luigi Orsenigo

Additional information is available for the following registered author(s):

Abstract

Vaccine production is now at the heart of the debate on development. This paper argues that, as well as economic policies to address market failures, development policies aimed at fostering vaccine innovation should also consider the institutional and organisational uncertainties. The International Aids Vaccine Initiative (IAVI), a product development PPP, is attempting to increase vaccine production for neglected diseases by acting both as a broker and integrator of knowledge. Within IAVI and perhaps other PPPs there is a related tension between an emphasis on private pharmaceutical sector efficiency and sustainable development activities that requires understanding and managing if PPPs are to successfully reach their goals. La production de vaccins est maintenant au coeur du débat sur le développement. L'objet de cet article est de montrer que tant les politiques économiques visant les défaillances de marché, que les politiques de développement qui cherchent à promouvoir l'innovation en matière de vaccins devraient s'intéresser aux incertitudes organisationnelles et institutionnelles. L'Initiative internationale de vaccins contre le SIDA (IAVI) issue d'un partenariat public-privé (PPP), essaie d'accroître la production de vaccins pour les maladies négligées en agissant en tant qu'intermédiaire ou intégrateur de savoirs. Dans le cadre de IAVI et peut être d'autres PPP, une condition du succès consiste à comprendre et prendre en compte les tensions existantes entre un accent mis sur l'efficacité du secteur pharmaceutique privé d'une part et des activités de développement durable d'autre part.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help file. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.informaworld.com/openurl?genre=article&doi=10.1080/09578810601144350&magic=repec&7C&7C8674ECAB8BB840C6AD35DC6213A474B5
File Format: text/html
File Function:
Download Restriction: Access to full text is restricted to subscribers.

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Taylor and Francis Journals in its journal The European Journal of Development Research.

Volume (Year): 19 (2007)
Issue (Month): 1 ()
Pages: 100-117
Download reference. The following formats are available: HTML, plain text, BibTeX, RIS (EndNote), ReDIF
Handle: RePEc:taf:eurjdr:v:19:y:2007:i:1:p:100-117

Contact details of provider:
Web page: http://www.informaworld.com/smpp/title~content=t713635016

Order Information:
Web: http://www.tandf.co.uk/journals/subscription.html

For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).

Related research
Keywords:

Statistics
Access and download statistics

Did you know? You too can volunteer with RePEc.

This page was last updated on 2008-7-16.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.